Visualization of interaction between inorganic nanoparticles and bacteria or fungi

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 1085-1094

  Chwalibog, André ^a   Sawosz, Ewa ^b   Hotowy, Anna ^a   Szeliga, Jacek ^b   Mitura, Stanislaw ^c   Mitura, Katarzyna ^c   Grodzik, Marta ^b   Orlowski, Piotr ^b   Sokolowska, Aleksandra ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^d WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Candida albicans; Diamond; Gold; Morphology; Nanoparticles; Platinum; Silver; Staphylococcus aureus

Indexed keywords

DIAMOND NANOPARTICLE; GOLD NANOPARTICLE; METAL NANOPARTICLE; NANOCARRIER; PLATINUM NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; DIAMOND; GOLD; NANOCOMPOSITE; NANOPARTICLE; PLATINUM; SILVER;

ARTICLE; BINDING AFFINITY; CANDIDA ALBICANS; CELL DAMAGE; CELL DESTRUCTION; CELL MEMBRANE; CELL WALL; CHEMICAL INTERACTION; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; MEMBRANE POTENTIAL; NONHUMAN; SELF ORGANIZATION; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; COLLOID; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECT; METABOLISM;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; FUNGI; STAPHYLOCOCCUS AUREUS;

CANDIDA ALBICANS; COLLOIDS; DIAMOND; DRUG DELIVERY SYSTEMS; GOLD; NANOCOMPOSITES; NANOPARTICLES; PLATINUM; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 79954538940     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S13532     Document Type: Article

References (57)

1. Paukner S, Kohl G, Jalava K, Lubitz W. Sealed bacterial ghosts - novel targeting vehicles for advances drug delivery of water-soluble substances. J Drug Target. 2003;11:151-161.
2. Paukner S, Stiedl T, Kudela P, Bizik J, Al Laham F, Lubitz W. Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery. Expert Opin Drug Deliv. 2006;3:11-22.
3. Akin D, Sturgis J, Ragheb K, et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat Nanotechnol. 2007;2:441-449.
4. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339: 520-532.
5. Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol. 1996;44:157-164.
6. Renders NHM, van Belkurn A, Overbeek SE, Mouton JW, Hrbrugh HA. Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients. Clin Microbiol Infect. 1997;3:216-221.
7. Koort JK, Makinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18FFDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004;45:1406-1411.
8. Elizur A, Orscheln RC, Ferkol TW, et al. Panton-Valentine leukocidinpositive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131:1718-1725.
9. Amsterdam D, Coombs G, Dowzicky M. Antimicrobial susceptibility of bloodstream isolates of Staphylococcus aureus: Global results from the tigecycline evaluation and surveillance trial, 2004-2008. Am J Infect Dis. 2010;6:1-7.
10. Big C, Malani PN. Staphylococcus aureus bloodstream infections in older adults: Clinical outcomes and risk factors for in-hospital mortality. J Am Geriatr Soc. 2010;58:300-305.
11. MacCallum D. Candida albicans: New insight in infection, disease, and treatment. In: Kavanagh K, editor. New Insight in Medical Mycology. Berlin, Germany: Springer-Verlag; 2007.
12. Stinnett EA, Childers NK, Wright JT, Rodu BK, Bradley EL Jr. The detection of oral Candida in pediatric leukemia patients. Pediatr Dent. 1992;14:236-239.
13. Cantu J. Hepatosplenic candidiasis in patients with acute leukemia. Internet J Emerg Intens Care Med. 2005;8(2).
14. Dongari-Bagtzoglou A, Dwivedi P, Ioannidou E, et al. Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009;24:249-254.
15. Basu S, Chakraborty D, Das S. Susceptibility of Candida species isolated from HIV infected and newborn candidaemia patients to amphotericin B. OnLine J Biol Sci. 2010;10:109-113.
16. Hernandez-Sierra JF, Ruiz F, Pena DC, et al. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide and gold. Nanomedicine NBM. 2008;4:237-240.
17. Dror-Ehre A, Mamane H, Belenkova T, Markovich G, Adin A. Silver nanoparticle - E. coli colloidal interaction in water and effect on E. coli survival. J Colloid Interface Sci. 2009;339:521-526.
18. Eby DM, Shaeublin NM, Farrington KE, Hussain SM, Johnson GR. Lysozyme catalyzes the formation of antimicrobial silver nanoparticles. ACS Nano. 2009;3:984-994.
19. Panacek A, Kolar M, Vecerova R, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials. 2009;30:6333-6340.
20. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76-83.
21. Beachey EH. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Disease. 1881;143:325-345.
22. Munro C. Candida albicans cell wall mediated virulence. In: Ashbee HR, Bignell EM, editors. Pathogenic Yeasts. The Yeast Handbook. Berlin, Germany: Springer-Verlag; 2010.
23. Sawosz E, Chwalibog A, Szeliga J, et al. Visualization of gold and platinum nanoparticles interacting with Salmonella enteritidis and Listeria monocytogenes. Int J Nanomed. 2010;5:631-637.
24. Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346-2353.
25. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73:1712-1720.
26. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology. 2007;18:225103-225111.
27. Li W-R, Xie X-B, Shi Q-S, Zeng H-Y, Ou-Yang Y-S, Chen Y-B. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2010;85:1115-1122.
28. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv Colloid Interface Sci. 2009; 145:83-96.
29. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine NBM. 2007;3:95-101.
30. Kvitek L, Vanickova M, Panacek A, et al. Initial study on the toxicity of silver nanoparticles (NPs) against Paramecium caudatum. J Phys Chem. 2009;113:4296-4300.
31. Kim K-J, Sung WS, Suh BK, et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometal. 2009; 22:235-242.
32. Alt V, Bechert T, Steinrucke P, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25:4383-4391.
33. Greulich C, Kittler S, Epple M, Muhr G, Koller M. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg. 2009;394:495-502.
34. Hsin Y-H, Chen C-F, Huang S, et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179:130-139.
35. Sawosz E, Binek M, Grodzik M, et al. Influence of hydrocolloidal silver nanoparticles on gastrointestinal microflora and morphology of enterocytes of quails. Arch Anim Nutr. 2007;61:444-451.
36. Sawosz E, Grodzik M, Zielinska M, Niemiec T, Olszańska B, Chwalibog A. Nanoparticles of silver do not affect growth, development and DNA oxidative damage in chicken embryos. Arch Geflügelk. 2009;73:208-213.
37. Niemeyer CM. Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science. Angew Chem Int Ed. 2001;40:4128-4158.
38. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325-327.
39. Thomas M, Klibanov AM. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A. 2003;100:9138-9143.
40. Tkachenko AG, Xie H, Liu Y, et al. Cellular trajectories of peptidemodified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem. 2004;15: 482-490.
41. Mukherjee P, Bhattacharya R, Bone N, et al. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): Enhancing apoptosis. J Nanobiotechnology. 2007;5:4.
42. Zheng Y, Sache L. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat Res. 2009;172:114-119.
43. Cheng Y, Samia AC, Li J, Kenney ME, Resnick A, Burda C. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir. 2010;26:2248-2255.
44. Rosenberg B, van Camo R, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from platinum electrode. Nature. 1965;205:698-699.
45. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol. 2002;42: 317-325.
46. Schrand AM, Huang H, Carlson C, et al. Are diamond nanoparticles cytotoxic? J Phys Chem B. 2007;111:2-7.
47. Lam R, Ho D. Nanodiamonds as vehicles for systemic and localized drug delivery. Expert Opin Drug Deliv. 2009;6:883-895.
48. Bakowicz K. Bioactivity of Diamond. PhD Thesis. Technical University of Lodz: Poland; 2003.
49. Bakowicz-Mitura K, Bartosz G, Mitura S. Influence of diamond powder particles on human gene expression. Surf Coat Tech. 2007;201: 6131-6135.
50. Lam R, Chen M, Pierstorff E, Huang H, Osawa E, Ho D. Nanodiamondembedded microfilm devices for localized chemotherapeutic elution. ACS Nano. 2008;2:2095-2102.
51. Yuan Y, Wang X, Jia G, et al. Pulmonary toxicity and translocation of nanodiamonds in mice. Diamond and Related Materials. 2010;19:291-299.
52. Danilenko VV. Synthesizing and Sintering of Diamond by Explosion. Moscow, Russia: Energoatomizdat; 2003.
53. Mitura S, Mitura K, Niedzielski P, Louda P, Danilenko V. Nanocrystalline diamond, its synthesis, properties and applications. J Achieve Mater Manuf Eng. 2006;16:9-16.
54. Schärtl W, editor. Light Scattering from Polymer Solutions and Nanoparticle Dispersions. Berlin, Germany: Springer-Verlag; 2007.
55. Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130-180.
56. Panacek A, Kvitek L, Prucek R, et al. Silver colloid nanoparticles: Synthesis, characterization and their antibacterial activity. J Phys Chem B. 2006;110:16248-16253.
57. Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, Martinez-Mendoza JR, Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res. 2008;10: 1343-1348.